» Articles » PMID: 37296867

Tackling Insomnia Symptoms Through Vestibular Stimulation in Patients with Breast Cancer: A Perspective Paper

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jun 10
PMID 37296867
Authors
Affiliations
Soon will be listed here.
Abstract

Insomnia symptoms are common among patients with breast cancer (BC; 20-70%) and are predictors of cancer progression and quality of life. Studies have highlighted sleep structure modifications, including increased awakenings and reduced sleep efficiency and total sleep time. Such modifications may result from circadian rhythm alterations consistently reported in this pathology and known as carcinogenic factors, including lower melatonin levels, a flattened diurnal cortisol pattern, and lower rest-activity rhythm amplitude and robustness. Cognitive behavioral therapy and physical activity are the most commonly used non-pharmacological interventions to counter insomnia difficulties in patients with BC. However, their effects on sleep structure remain unclear. Moreover, such approaches may be difficult to implement shortly after chemotherapy. Innovatively, vestibular stimulation would be particularly suited to tackling insomnia symptoms. Indeed, recent reports have shown that vestibular stimulation could resynchronize circadian rhythms and improve deep sleep in healthy volunteers. Moreover, vestibular dysfunction has been reported following chemotherapy. This perspective paper aims to support the evidence of using galvanic vestibular stimulation to resynchronize circadian rhythms and reduce insomnia symptoms in patients with BC, with beneficial effects on quality of life and, potentially, survival.

Citing Articles

Exploration of effects of galvanic vestibular stimulation on circadian rhythms and its associations with sleep and spatial memory in patients with breast cancer: The ICANSLEEP-2 protocol.

Galin M, de Girolamo L, Clarisse B, Segura-Djezzar C, Glockner F, Elia C PLoS One. 2024; 19(7):e0306462.

PMID: 39083526 PMC: 11290633. DOI: 10.1371/journal.pone.0306462.


Visual analysis of the research frontiers, hotspots and trends of exercise therapy intervention in tumor-related sleep-wake disorders.

Han J, Zhang J, Zhang L, Guo J, Peng X, Ying C Front Oncol. 2024; 14:1392844.

PMID: 38741781 PMC: 11089126. DOI: 10.3389/fonc.2024.1392844.


Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses.

Anderson G Explor Target Antitumor Ther. 2023; 4(5):962-993.

PMID: 37970210 PMC: 10645470. DOI: 10.37349/etat.2023.00176.

References
1.
Cash E, Sephton S, Chagpar A, Spiegel D, Rebholz W, Zimmaro L . Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery. Brain Behav Immun. 2015; 48:102-14. DOI: 10.1016/j.bbi.2015.02.017. View

2.
Pasquier F, Bessot N, Martin T, Gauthier A, Bulla J, Denise P . Effect of vestibular stimulation using a rotatory chair in human rest/activity rhythm. Chronobiol Int. 2020; 37(8):1244-1251. DOI: 10.1080/07420528.2020.1797762. View

3.
Jakobsen G, Gjeilo K, Hjermstad M, Klepstad P . An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer-Implications for Health Care Providers and Clinical Research. Cancers (Basel). 2022; 14(16). PMC: 9406296. DOI: 10.3390/cancers14163933. View

4.
Monfort S, Pan X, Patrick R, Singaravelu J, Loprinzi C, Lustberg M . Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study. Gait Posture. 2016; 48:237-242. PMC: 4969166. DOI: 10.1016/j.gaitpost.2016.06.011. View

5.
Silberfarb P, Hauri P, Oxman T, Schnurr P . Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993; 11(5):997-1004. DOI: 10.1200/JCO.1993.11.5.997. View